Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Electronic Prescribing in Hospital Ambulatory Care Clinics

This study has been completed.
Sponsor:
Collaborator:
Health Canada
Information provided by:
Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT00252395
First received: November 9, 2005
Last updated: NA
Last verified: November 2005
History: No changes posted

November 9, 2005
November 9, 2005
August 2005
Not Provided
Total prescribing error, as measured by the number of call backs received from pharmacists.
Same as current
No Changes Posted
  • a) Interactions
  • b) Dosing and route of administration errors
  • c) Pack errors
  • d) Legibility errors
Same as current
Not Provided
Not Provided
 
Evaluation of Electronic Prescribing in Hospital Ambulatory Care Clinics
Effects of Electronic Prescribing on Safety and Quality in Hospital-Based Ambulatory Are: a Randomised Controlled Trial

All reliably evaluated POE systems to date have been desktop computer based, but now there is widespread use and acceptance among physicians of PDA devices for a variety of purposes. Clinicians report that drug information on a PDA improved their access to information and efficiency while reducing their self perceived error rates6. The use of these devices for information retrieval in clinical settings is expected to grow as wireless communication becomes more ubiquitous and as more applications become available6,7. During the past decade there has been a growing awareness of several issues aimed at promoting safer health care for our patients – point of care information technology is one of the keys.

To this end we have worked with a Canadian company, Drugmagnet, to develop and implement PDA-based electronic prescribing system within a major Canadian academic health centre. This is a cluster randomised trial, in which access to and use of the e-prescribing system is switched on and off for randomly chosen weeks, thus time serves as the randomized element.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Electronic Prescribing
Device: PDA-based Electronic Prescribing Software
Not Provided
Dainty KN, Adhikari NK, Kiss A, Quan S, Zwarenstein M. Electronic prescribing in an ambulatory care setting: a cluster randomized trial. J Eval Clin Pract. 2012 Aug;18(4):761-7. doi: 10.1111/j.1365-2753.2011.01657.x. Epub 2011 Mar 18.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
August 2006
Not Provided

Inclusion Criteria:

  • active staff physician at Sunnybrook & Women's College HSC

Exclusion Criteria:

  • inadequate prescribing practice (minimum number)
Both
Not Provided
Yes
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00252395
S&W e-RX, 6804-15-2003/5590024
Not Provided
Not Provided
Sunnybrook Health Sciences Centre
Health Canada
Study Director: Merrick F Zwarenstein, MBBCH Institute for Clinical Evaluative Science
Principal Investigator: William J Sibbald, MD, MPH Sunnybrook & Women's College Health Sciences Centre
Sunnybrook Health Sciences Centre
November 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP